Preclinical and clinical data, though predominantly derived from case reports and small cohort studies to date, consistently indicate that GLP-1 RAs - including liraglutide, semaglutide, and the dual GIP/GLP-1 RA tirzepatide - can induce clinically meaningful weight loss, suppress the characteristic severe hyperphagia, and improve key cardiometabolic parameters in both heterozygous and homozygous MC4R variant carriers
The pen works by binding itself to receptors in the brain that are responsible for regulating appetite
It is made by Novo Nordisk and sold under brand names like Wegovy, Ozempic, and Rybelsus
Browse all Peptides & GLP-1 education This is independent editorial coverage
Simple: one flat monthly charge that covers everything your physician visit, medication, supplies, and shipping
This advice applies universally, but it bears repeating for tirzepatide users who may already be dealing with nausea and digestive discomfort